Patients with alopecia areata frequently report severe psychological stress preceding disease onset or flare. While stress doesn't cause alopecia areata in patients without genetic susceptibility, it appears to be a meaningful trigger in genetically predisposed individuals. The biological pathway involves bidirectional connections between the nervous and immune systems mediated by neuropeptides, cytokines, and HPA axis stress hormones.

Specific stress-immune mechanisms relevant to alopecia areata include substance P release from cutaneous nerve fibres (which can activate mast cells around hair follicles), cortisol-mediated alterations in lymphocyte distribution, and direct effects of stress on the immune privilege of the hair follicle (the normal mechanism that prevents immune attack on growing follicles, which appears to fail in alopecia areata). The 2018 work from the Paus laboratory at the University of Miami documented these specific pathways in human scalp tissue under controlled stress conditions.

Practical implications: stress management is reasonable supportive therapy for alopecia areata patients, though it shouldn't be presented as primary treatment. Patients should not feel they 'caused' their hair loss through stress, the genetic susceptibility is the underlying issue, and stress is a trigger rather than the disease itself. Psychological support, cognitive behavioural therapy, and treatments for diagnosed anxiety or depression all contribute to overall wellbeing during alopecia areata episodes. Some specialists explicitly include mind-body interventions in comprehensive alopecia areata management protocols.